Recurrent, Refractory, or High Risk Leukemias
1 clinical trials · Condition
◉ Watch Recurrent, Refractory, or High Risk Leukemias
| Record | Firm | Date |
|---|---|---|
| Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome (NCT02670525) | Dana-Farber Cancer Institute | 2016-08-17 |
Track Recurrent, Refractory, or High Risk Leukemias automatically
Every clearance here is in the API, with alerts when new ones post.